COVERAGE HUB
$NRIX
1 articles in last 30 days
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
0
1-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 3 ARTICLES
Truist is Bullish on Nurix Therapeutics, Inc. (NRIX)
Truist analyst Gregory Renza's price target increase for NRIX from $30 to $32 reflects incremental confidence in the biotech company's...
Truist is Bullish on Nurix Therapeutics, Inc. (NRIX)
Truist analyst Gregory Renza elevated confidence in NRIX by raising the price target modestly from $30 to $32, representing a 6.7%...
Nurix Therapeutics Deal With Roche Is Worth Betting On (NASDAQ:NRIX)
NRIX announced a partnership with pharmaceutical giant Roche, representing validation of its lead candidate bexobrutinib and potential...